
TriSalus Life Science’s drug delivery shows efficacy against pancreatic cancer
WESTMINSTER -- A phase 1b clinical trial shows that administering a concentrated dose of anti-CEA CAR-T cells precisely at the site of a solid tumor by means of TriSalusLife Sciences unique... Read More
Wednesday November 7, 2018